Drug – bio-affecting and body treating compositions – Lymphokine
Patent
1997-12-18
1998-12-01
Feisee, Lila
Drug, bio-affecting and body treating compositions
Lymphokine
435 2, 435375, 435378, 530351, 530399, A61K 3819, C12N 500, C12N 1519
Patent
active
058434232
ABSTRACT:
Ligands for flt3 receptors capable of transducing self-renewal signals to regulate the growth, proliferation or differentiation of progenitor cells and stem cells are disclosed. The invention is directed to flt3-L as an isolated protein, the DNA encoding the flt3-L, host cells transfected with cDNAs encoding flt3-L, compositions comprising flt3-L, methods of improving gene transfer to a mammal using flt3-L, and methods of improving transplantations using flt3-L. Flt3-L finds use in treating patients with anemia, AIDS and various cancers.
REFERENCES:
patent: 5061620 (1991-10-01), Tsukamoto et al.
patent: 5270458 (1993-12-01), Lemischka
patent: 5283354 (1994-02-01), Lemischka
patent: 5326558 (1994-07-01), Turner et al.
patent: 5367057 (1994-11-01), Lemischka
patent: 5397706 (1995-03-01), Correa et al.
patent: 5399493 (1995-03-01), Emerson et al.
patent: 5437994 (1995-08-01), Emerson et al.
patent: 5453357 (1995-09-01), Hogan
patent: 5459069 (1995-10-01), Palsson et al.
patent: 5525708 (1996-06-01), Nocka et al.
patent: 5548065 (1996-08-01), Lemischka
patent: 5554512 (1996-09-01), Lyman et al.
de Vries et al., Exp. Hematology, vol. 22(8):724 (1994) abstract #174.
Small, D. et al., PNAS, vol. 91(2):459 (1994).
Zeigler et al., Blood, 84(8):2422 (1994).
de Vries et al., Blood, 84(10), Suppl. 1, p. 279a, (1994) abstract #1100.
Hannum et al., Nature, 368:643 (1994).
Broxmeyer et al., Blood Cells, 20(2-3):492 (1994).
de Vries et al., J. of Cell Biochem., Suppl. 18B, p. 177, (1994) abstract #H100.
Stewart et al., Blood, 81:2283 (1993).
Rossner et al., Cell Growth & Differentiation, 5(5):549 (1994).
Papayannopoulo et al. Blood 90: 620-629 (1997).
Beckmann M. Patricia
Lyman Stewart D.
Feisee Lila
Gambel Phillip
Immunex Corporation
Malaska Stephen L.
LandOfFree
Methods of stimulating hematopoietic cells with flt3-ligand does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods of stimulating hematopoietic cells with flt3-ligand, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods of stimulating hematopoietic cells with flt3-ligand will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2393294